A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
IDEAYA Biosciences
Orano Med LLC
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
General Oncology, Inc.
Valent Technologies, LLC
Lyell Immunopharma, Inc.
Zhejiang University
Biomea Fusion Inc.
Blueprint Medicines Corporation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aurigene Discovery Technologies Limited
Chongqing Precision Biotech Co., Ltd
Ipsen
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
Emory University
Celgene
University Health Network, Toronto
Jiangsu HengRui Medicine Co., Ltd.
Eastern Hepatobiliary Surgery Hospital
Eastern Hepatobiliary Surgery Hospital
H. Lee Moffitt Cancer Center and Research Institute
Rutgers, The State University of New Jersey
University of Illinois at Chicago
Cellectar Biosciences, Inc.
Bristol-Myers Squibb
National Cancer Institute (NCI)
Pharmacyclics LLC.
National Taiwan University Hospital
Light Sciences LLC